April 2, 2026Aspect Biosystems secures $79-million in federal funding to advance 3-D tissue printing technology3 min read
February 5, 2026the age of breakthroughsA promising vaccine aims to prevent cancer in people with Lynch syndrome5 min read
January 20, 2026Aspect Biosystems expands partnership with Novo Nordisk to develop diabetes treatment3 min read
January 3, 2026Would you clone your pet? The seemingly sci-fi practice is becoming more mainstream4 min read
November 17, 2025Zymeworks stock hits four-year high on promising results from digestive cancer trial3 min read
October 18, 2025opinionCrispr gave humans the power to remake ourselves. What will we do with it? Matt Ridley11 min read
September 3, 2025Kardium gets FDA greenlight to sell in the U.S. device that treats common heart problem3 min read
September 2, 2025opinionDefence spending must include health spending tooCarl Hansen and Peter Zandstra4 min read
August 25, 2025Contra Guys: This revolutionary biotech pioneer has joined our watchlistPhilip MacKellar4 min read
August 13, 2025leadership labBiomanufacturing is entering a new era and its future depends on the talentRoger-Ketcha Ngassam and Amine Kamen3 min read
July 16, 2025Healthy babies born in Britain after scientists used DNA from three people to avoid genetic disease4 min read
July 13, 2025Biotech entrepreneur Francesco Bellini uplifted the next generation of Canadian scientists3 min read
July 8, 2025‘Lord of the Rings’ director partners with biotech company looking to resurrect extinct New Zealand bird3 min read
July 7, 202523andMe founder can re-acquire company after judge rejects California’s attempt to delay sale2 min read
July 4, 2025Small caps to watch: Biopharm stock surges on takeover deal, Cargojet wins contract extension, and more8 min read
July 1, 2025Court approves Anne Wojcicki’s bid to buy genetic testing company 23andMe for $305-million3 min read
June 20, 2025Islet cell transplant trial outcome ‘major milestone’ toward cure for diabetes4 min read
